165 related articles for article (PubMed ID: 10745628)
1. Torsade de pointes associated with hypokalemia after anthracycline treatment in a patient with acute lymphocytic leukemia.
Kishi S; Yoshida A; Yamauchi T; Tsutani H; Lee JD; Nakamura T; Naiki H; Ueda T
Int J Hematol; 2000 Feb; 71(2):172-9. PubMed ID: 10745628
[TBL] [Abstract][Full Text] [Related]
2. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
Arbel Y; Swartzon M; Justo D
Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
[TBL] [Abstract][Full Text] [Related]
3. The perfect storm: Torsades de Pointes in a child with leukemia.
Bagatell R; Hainstock M; Lowe MC; Barber BJ; Samson RA
Pediatr Blood Cancer; 2007 Dec; 49(7):996-9. PubMed ID: 16333840
[TBL] [Abstract][Full Text] [Related]
4. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance.
Faigel DO; Metz DC; Kochman ML
Am J Gastroenterol; 1995 May; 90(5):822-4. PubMed ID: 7733096
[TBL] [Abstract][Full Text] [Related]
5. Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers.
Milberg P; Fleischer D; Stypmann J; Osada N; Mönnig G; Engelen MA; Bruch C; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2007 Jan; 102(1):42-51. PubMed ID: 16817026
[TBL] [Abstract][Full Text] [Related]
6. QT interval prolongation, torsade de pointes and renal disease.
Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced long QT and torsade de pointes: recent advances.
Kannankeril PJ; Roden DM
Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
[TBL] [Abstract][Full Text] [Related]
8. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
9. Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy.
Naito K; Kobayashi M; Sahara N; Shigeno K; Nakamura S; Shinjo K; Tobita T; Takeshita A; Ohno R; Ohnishi K
Int J Hematol; 2006 May; 83(4):318-23. PubMed ID: 16757431
[TBL] [Abstract][Full Text] [Related]
10. [Torsade de pointes ventricular tachycardia in a patient with acute myelocytic leukemia].
Morioka M; Kakinoki Y; Katagiri M; Iwasaki H; Gotohda Y; Kobayashi T; Tanaka M; Sakurada K; Miyazaki T
Rinsho Ketsueki; 1991 Sep; 32(9):1009-11. PubMed ID: 1942537
[TBL] [Abstract][Full Text] [Related]
11. Torsades de pointes associated with voriconazole use.
Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
[TBL] [Abstract][Full Text] [Related]
12. [An unusual cause of cardiac arrest].
Campana A; Manzo M; Brigante M; Marrazzo N; Melchiorre G
Ital Heart J Suppl; 2003 Jun; 4(6):510-3. PubMed ID: 19400057
[TBL] [Abstract][Full Text] [Related]
13. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
14. Torsade de pointes and sudden death associated with diabetic autonomic diarrhoea--a case report.
Quek DK; H'ng PK
Singapore Med J; 1993 Jun; 34(3):266-70. PubMed ID: 8266190
[TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin and torsade de pointes.
Dale KM; Lertsburapa K; Kluger J; White CM
Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
[TBL] [Abstract][Full Text] [Related]
16. [Torsade de pointes and use of phenothiazine and diuretic].
Jarchovsky J; Zamir D; Plavnik L
Harefuah; 1991 Dec; 121(11):435-6. PubMed ID: 1686258
[TBL] [Abstract][Full Text] [Related]
17. [Severe ventricular arrhythmia secondary to indapamide-induced hypopotassemia].
Guzzini F; Baroffio R; Coppetti D; Gasparini P
Clin Ter; 1990 Nov; 135(4):283-7. PubMed ID: 1705875
[TBL] [Abstract][Full Text] [Related]
18. [Pause-dependent Torsade de Pointes following acute myocardial infarction].
Tomcsányi J; Somlói M; Vecsey T
Orv Hetil; 2003 Jul; 144(30):1489-91. PubMed ID: 14569679
[TBL] [Abstract][Full Text] [Related]
19. Female preponderance in ibutilide-induced torsade de pointes.
Gowda RM; Khan IA; Punukollu G; Vasavada BC; Sacchi TJ; Wilbur SL
Int J Cardiol; 2004 Jun; 95(2-3):219-22. PubMed ID: 15193823
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
